These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4720490)

  • 21. Antilipemic action of heparin.
    Markwardt F
    Thromb Diath Haemorrh; 1975 Feb; 33(1):73-6. PubMed ID: 1091020
    [No Abstract]   [Full Text] [Related]  

  • 22. [Lipoprotein lipase activity in healthy subjects and patients with metabolic disorders].
    Herrmann W; Reuter W; Schütz C; Herbst A; Würzberger G
    Z Gesamte Inn Med; 1981 Apr; 36(7):298-301. PubMed ID: 7281830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin lysolecithin, and platelet function.
    Joist JH; Mustard JF
    Adv Exp Med Biol; 1975; 52():255-61. PubMed ID: 1124700
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of carbohydrates on the vascular wall, heparin levels and the activity of blood lipoprotein lipase in patients with coronary atherosclerosis].
    Chunakova EP; Meshcheriakova VA
    Vrach Delo; 1969 Feb; 2():14-8. PubMed ID: 5779376
    [No Abstract]   [Full Text] [Related]  

  • 25. [Post-heparin plasmatic lipolysis. Physiological and physiopathological significance].
    Cucuianu M; Popescu A; Opincaru A
    Stud Cercet Med Interna; 1968; 9(1):3-12. PubMed ID: 4874732
    [No Abstract]   [Full Text] [Related]  

  • 26. Blood coagulability and lipid metabolism in patients with coronary insufficiency.
    Panchenko VM; Bazaz'yan GG
    Fed Proc Transl Suppl; 1966; 25(5):800-2. PubMed ID: 5223562
    [No Abstract]   [Full Text] [Related]  

  • 27. [Disorders of carbobohydrate and other types of metabolism in patients with coronary arteriosclerosis].
    Sil'nitskiĭ PA; Avenirova ZA; Orkodashvili LSh
    Sov Med; 1974 Jun; 37(6):18-22. PubMed ID: 4845252
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoprotein-lipase modifications in subjects treated with a synthetic, heparin-like polyanion (SP 54).
    Frandoli G; Spreafico PL
    Farmaco Prat; 1972 Sep; 27(9):514-8. PubMed ID: 5074781
    [No Abstract]   [Full Text] [Related]  

  • 29. [Lipoprotein lipase-mediated myopathy: implications for lipid metabolism and atherogenesis].
    Merkel M; Radner H; Greten H
    Med Klin (Munich); 2003 Dec; 98(12):679-84. PubMed ID: 14685668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of glucose on lipoprotein lipase in plasma].
    Bolzano K; Sailer S; Sandhofer F; Braunsteiner H
    Wien Z Inn Med; 1971; 52(1):27-30. PubMed ID: 5540815
    [No Abstract]   [Full Text] [Related]  

  • 31. [Genetics of atherosclerosis. I. Lipid metabolism indices in healthy young individuals with due consideration to hereditary aggravating circumstances and the degree of their severity].
    Dzizinskiĭ AA; Solovenchuk LL; Kaznacheev VP
    Kardiologiia; 1973 Feb; 13(2):44-50. PubMed ID: 4775783
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence of an effect of inhaled disodium cromoglycate on lipid metabolism in man: enhanced lipolysis and decreased plasma post-heparin lipase activities.
    Sommariva D; Zanaboni L; Bonfiglioli D; Cogo R; Fasoli A
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):122-7. PubMed ID: 6769825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Atherogenicity of sucrose].
    Markelova VG; Liapkov BG
    Vopr Pitan; 1971; 30(1):20-4. PubMed ID: 5572188
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of insulin on plasma postheparin lipoprotein lipase activity in patients with coronary sclerosis and in control subjects.
    Orosz L; Erdélyi G; Romics L; Gerö S
    Atherosclerosis; 1973; 18(2):265-75. PubMed ID: 4742852
    [No Abstract]   [Full Text] [Related]  

  • 35. Developmental changes of myocardial metabolism. II. Myocardial metabolism of fatty acids in the early postnatal period in dogs.
    Breuer E; Barta E; Zlatos L; Pappová E
    Biol Neonat; 1968; 12(1):54-64. PubMed ID: 5638825
    [No Abstract]   [Full Text] [Related]  

  • 36. Exercise and lipid metabolism.
    Oscai LB
    Prog Clin Biol Res; 1981; 67():383-90. PubMed ID: 7029565
    [No Abstract]   [Full Text] [Related]  

  • 37. Nicotine and arteriosclerosis. An experimental contribution to the influence of nicotine on fat metabolism.
    Schievelbein H; Londong V; Londong W; Grumbach H; Remplik V
    Z Klin Chem Klin Biochem; 1970 May; 8(3):190-6. PubMed ID: 5470739
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lipid metabolism disorders in patients with chronic renal failure].
    Zdrojewski Z
    Pol Tyg Lek; 1982 May; 37(13):391-3. PubMed ID: 7134045
    [No Abstract]   [Full Text] [Related]  

  • 39. Observations on heparin-induced clearing activity in ischaemic heart disease and the effect of prolonged heparin therapy.
    NESTEL PJ
    Australas Ann Med; 1961 Feb; 10():29-32. PubMed ID: 13728417
    [No Abstract]   [Full Text] [Related]  

  • 40. [Determination of plasma lipoprotein lipase].
    Kröning G; Rechenberger J
    Z Gesamte Inn Med; 1972 Mar; 27(6):254-7. PubMed ID: 5048586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.